We aim to be the leading specialty pharmaceutical group to improve the quality of human life
Investor Relations
Corporate Information
Financial Information
Stock Information
Newsroom
Webcasting
Information Request

Email This Print This Presentation Slides

1H2006 Results Briefing

4.48 MB

[ Click here to download ]

Q2 FY2005 (1st Half) Result Briefing

0.53 MB

[ Click here to download ]

IPO Launch

0.59 MB

[ Click here to download ]